MANUEL PEREZ: Open Payments
NPI 1225611221 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$232 in 9 payments from 7 companies in 2025. Trend: 2023 $19 · 2024 $226 · 2025 $232
Food & beverage: $232
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 2 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $45 |
| E.R. Squibb & Sons, L.L.C. | 1 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $32 |
| Gilead Sciences, Inc. | 1 | $24 |
| Eisai Inc. | 1 | $21 |
| Incyte Corporation | 1 | $17 |
Products named: OPDIVO, DATROWAY, Enhertu, Trodelvy, FRUZAQLA, ALUNBRIG, Lenvima, NIKTIMVO.
Industry payments across FL — which companies pay providers there.
